baclofen has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bédard, PJ; Gomez-Mancilla, B | 1 |
Bisht, R; Kumar, P; Majeed, AB; Pant, J; Prakash, A; Tyagi, RK | 1 |
2 other study(ies) available for baclofen and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Article | Year |
---|---|
Effect of nondopaminergic drugs on L-dopa-induced dyskinesias in MPTP-treated monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Atropine; Baclofen; Clonidine; Dopamine Agents; Drug Interactions; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca fascicularis; Meperidine; Methoxydimethyltryptamines; Neurotransmitter Agents; Yohimbine | 1993 |
Possible role of GABA-B receptor modulation in MPTP induced Parkinson's disease in rats.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Baclofen; Cerebral Cortex; Corpus Striatum; Cytokines; Disease Models, Animal; GABA-B Receptor Agonists; GABA-B Receptor Antagonists; Lipid Peroxidation; Male; Motor Activity; Organophosphorus Compounds; Oxidative Stress; Parkinsonian Disorders; Rats, Wistar; Receptors, GABA-B; Rotarod Performance Test | 2015 |